{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Huazhong University of Science and Technology, Wuhan, China",
    "Department of Anesthesiology, The 960th Hospital of People’s Liberation Army of China (PLA), Jinan, Shandong, China",
    "Department of Pharmacology, State Key Laboratory of Experimental Hematology, Tianjin Key Laboratory of Inflammatory Biology, School of Basic Medical Science, Tianjin Medical University, Tianjin, China",
    "7Adlai Nortye USA Inc., North Brunswick, NJ, USA",
    "National Taiwan University Hospital, Taipei, Taiwan",
    "1Renmin Hospital, Beijing, China",
    "6Adlai Nortye Biopharma Co., Ltd., Hangzhou, China",
    "Chinese Academy of Medicine, Shanghai, China",
    "The Chinese University of Hong Kong, Hong Kong SAR, China",
    "Beijing Cancer Hospital, Beijing, China",
    "Beijing Jishuitan Hospital, Beijing, China",
    "The University of Hong Kong, Hong Kong SAR, China",
    "Adlai Nortye Biopharma Co., Ltd., Hangzhou, China"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 13,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Jing Chen"
    },
    {
      "affs": [
        1
      ],
      "name": "Fei Wang"
    },
    {
      "affs": [
        2
      ],
      "name": "Shanshan Wang"
    },
    {
      "affs": [
        3
      ],
      "name": "Xuyang Song"
    },
    {
      "affs": [
        4
      ],
      "name": "Chia-Chi Lin"
    },
    {
      "affs": [
        5
      ],
      "name": "Xiaodong Tang"
    },
    {
      "affs": [
        6
      ],
      "name": "Xuyang Lu"
    },
    {
      "affs": [
        7
      ],
      "name": "Yutao Liu"
    },
    {
      "affs": [
        8
      ],
      "name": "Herbert H Loong"
    },
    {
      "affs": [
        9
      ],
      "name": "Liu Jiayong"
    },
    {
      "affs": [
        10
      ],
      "name": "Niu Xiaohui"
    },
    {
      "affs": [
        11
      ],
      "name": "Chung Cheung Thomas Yau"
    },
    {
      "affs": [
        12
      ],
      "name": "Archie Tse"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/dhgqxbwbxwdep.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0563",
  "fulltext_url": null,
  "id": "dhgqxbwbxwdep",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0563",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-04",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/dhgqxbwbxwdep.ris",
  "sources": [
    {
      "first_seen": "2026-11-05T14:21:13Z",
      "native_id": "58f31975e84e4fae8934ad3619734e0e",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0563"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "journal-openalex:2403|Immunotherapy and Immune Responses",
      "subfield": "immunology"
    },
    {
      "field": "medicine",
      "origin": "lcc:RC254-282",
      "subfield": "oncology"
    }
  ],
  "title": "563 Updated safety and efficacy of AN4005, an oral small-molecule PD-L1 inhibitor, in advanced solid tumors: phase I dose-escalation and expansion",
  "title_text": "563 Updated safety and efficacy of AN4005, an oral small-molecule PD-L1 inhibitor, in advanced solid tumors: phase I dose-escalation and expansion",
  "type": "peer-reviewed",
  "updated_at": "2026-11-06T14:20:42Z",
  "url": "https://research.draconitic.com/paper/dhgqxbwbxwdep",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}